RNA modifications: importance in immune cell biology and related diseases
L Cui, R Ma, J Cai, C Guo, Z Chen, L Yao… - Signal transduction and …, 2022 - nature.com
RNA modifications have become hot topics recently. By influencing RNA processes,
including generation, transportation, function, and metabolization, they act as critical …
including generation, transportation, function, and metabolization, they act as critical …
The potential role of N7-methylguanosine (m7G) in cancer
Y Luo, Y Yao, P Wu, X Zi, N Sun, J He - Journal of hematology & oncology, 2022 - Springer
Abstract N 7-methylguanosine (m7G), one of the most prevalent RNA modifications, has
recently attracted significant attention. The m7G modification actively participates in …
recently attracted significant attention. The m7G modification actively participates in …
N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis
Mis-regulated RNA modifications promote the processing and translation of oncogenic
mRNAs to facilitate cancer progression, while the molecular mechanisms remain unclear …
mRNAs to facilitate cancer progression, while the molecular mechanisms remain unclear …
tRNA dysregulation and disease
EA Orellana, E Siegal, RI Gregory - Nature Reviews Genetics, 2022 - nature.com
Abstract tRNAs are key adaptor molecules that decipher the genetic code during translation
of mRNAs in protein synthesis. In contrast to the traditional view of tRNAs as ubiquitously …
of mRNAs in protein synthesis. In contrast to the traditional view of tRNAs as ubiquitously …
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
R García-Vílchez, AM Añazco-Guenkova, S Dietmann… - Molecular cancer, 2023 - Springer
Newly growing evidence highlights the essential role that epitranscriptomic marks play in the
development of many cancers; however, little is known about the role and implications of …
development of many cancers; however, little is known about the role and implications of …
METTL1‐m7G‐EGFR/EFEMP1 axis promotes the bladder cancer development
X Ying, B Liu, Z Yuan, Y Huang, C Chen… - Clinical and …, 2021 - Wiley Online Library
Background The posttranscriptional modifications of transfer RNA (tRNA) are critical for all
aspects of the tRNA function and have been implicated in the tumourigenesis and …
aspects of the tRNA function and have been implicated in the tumourigenesis and …
METTL1 promotes hepatocarcinogenesis via m7G tRNA modification‐dependent translation control
Z Chen, W Zhu, S Zhu, K Sun, J Liao… - Clinical and …, 2021 - Wiley Online Library
Abstract Background N7‐methylguanosine (m7G) modification is one of the most common
transfer RNA (tRNA) modifications in humans. The precise function and molecular …
transfer RNA (tRNA) modifications in humans. The precise function and molecular …
QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism
Summary N 7-methylguanosine (m 7 G) modification, routinely occurring at mRNA 5′ cap
or within tRNAs/rRNAs, also exists internally in messenger RNAs (mRNAs). Although m 7 G …
or within tRNAs/rRNAs, also exists internally in messenger RNAs (mRNAs). Although m 7 G …
RNA modifications in cancer
Q Tang, L Li, Y Wang, P Wu, X Hou, J Ouyang… - British journal of …, 2023 - nature.com
Currently, more than 170 modifications have been identified on RNA. Among these RNA
modifications, various methylations account for two-thirds of total cases and exist on almost …
modifications, various methylations account for two-thirds of total cases and exist on almost …
Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation
X Zeng, G Liao, S Li, H Liu, X Zhao, S Li, K Lei… - Hepatology, 2023 - journals.lww.com
Conclusions: Our study sheds light on the pivotal role of METTL1 in modulating an
immunosuppressive microenvironment and demonstrated that interrupting METTL1‐TGF‐β2 …
immunosuppressive microenvironment and demonstrated that interrupting METTL1‐TGF‐β2 …